Julie Vose (@drjulievose) 's Twitter Profile
Julie Vose

@drjulievose

Chief, Hematology/Oncology @UNMC. @NebraskaMed. #BuffettCancerCenter. 2015-2016 President @ASCO. My opinions are my own.

ID: 2416787444

calendar_today29-03-2014 02:26:05

3,3K Tweet

3,3K Followers

412 Following

Alain Mina (@dralainmina) 's Twitter Profile Photo

Bidding farewell to a giant, a mentor, and above all, a friend. Congratulations Steven Pavletic M.D., Ph.D. on an incredible career; can’t wait to see what your next chapter holds. NIH National Cancer Institute

Bidding farewell to a giant, a mentor, and above all, a friend. Congratulations <a href="/StevenPavletic/">Steven Pavletic M.D., Ph.D.</a> on an incredible career; can’t wait to see what your next chapter holds. <a href="/NIH/">NIH</a> <a href="/theNCI/">National Cancer Institute</a>
Fred & Pamela Buffett Cancer Center (@buffettcancer) 's Twitter Profile Photo

This #CancerResearchMonth, we’re shining a light on prevention-focused science—the first step in saving lives. Our Cancer Prevention & Control Program works to reduce cancer burden through community-informed research & evidence-based interventions #NCRM25 bit.ly/3GBqbuP

OncoDaily (@oncodaily) 's Twitter Profile Photo

Vijaya Bhatt (Vijaya R Bhatt, MBBS, MS) Shares Phase II Results on Geriatric-Guided AML Treatment Selection University of Nebraska Medical Center Fred & Pamela Buffett Cancer Center Krishna Gundabolu MBBS; MS oncodaily.com/science/vijaya… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #AML #GeriatricOncology

Vijaya Bhatt (<a href="/VijayaRBhatt1/">Vijaya R Bhatt, MBBS, MS</a>) Shares Phase II Results on Geriatric-Guided AML Treatment Selection

<a href="/unmc/">University of Nebraska Medical Center</a> <a href="/BuffettCancer/">Fred & Pamela Buffett Cancer Center</a> <a href="/HematologistMD/">Krishna Gundabolu MBBS; MS</a> 

oncodaily.com/science/vijaya…

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #AML #GeriatricOncology
BioAscend (@bioascend) 's Twitter Profile Photo

Join us for #LEAD2025, a transformative conference empowering women leaders in the #hematology and #oncology spaces 📅 Date: September 26 - 27 📍 Location: Scottsdale, AZ Registration is now open: loom.ly/jylJ7Gc Dr. Julie Brahmer Dr. Catherine Lai Ana I. Velázquez Mañana, MD, MSc, FASCO Rachna Shroff, MD, MS, FASCO

Join us for #LEAD2025, a transformative conference empowering women leaders in the #hematology and #oncology spaces

đź“… Date: September 26 - 27
📍 Location: Scottsdale, AZ

Registration is now open: loom.ly/jylJ7Gc

<a href="/juliebrahmer/">Dr. Julie Brahmer</a> <a href="/katielaimd_mph/">Dr. Catherine Lai</a> <a href="/anavmanana/">Ana I. Velázquez Mañana, MD, MSc, FASCO</a> <a href="/rachnatshroff/">Rachna Shroff, MD, MS, FASCO</a>
Fred & Pamela Buffett Cancer Center (@buffettcancer) 's Twitter Profile Photo

Last Friday, we hosted a "Bench to Bedside" Investigator-Initiated Trials workshop to spark collaboration between basic, translational & clinical scientists—accelerating innovation & ensuring discoveries don't get stuck in the lab. #TeamScience #CancerResearch

Last Friday, we hosted a "Bench to Bedside" Investigator-Initiated Trials workshop to spark collaboration between basic, translational &amp; clinical scientists—accelerating innovation &amp; ensuring discoveries don't get stuck in the lab. #TeamScience #CancerResearch
Vaniam Group LLC (@vaniamgroup) 's Twitter Profile Photo

Join us to celebrate leadership, resilience, and progress at the 2025 Women Leaders in Oncology and Allies Event! HCP registration is now open: loom.ly/4XDuCvM #WomenInOncology #WLO2025 #LeadershipInCancerCare #EmpoweringChange

Join us to celebrate leadership, resilience, and progress at the 2025 Women Leaders in Oncology and Allies Event!
 
HCP registration is now open: loom.ly/4XDuCvM

#WomenInOncology #WLO2025 #LeadershipInCancerCare #EmpoweringChange
Fred & Pamela Buffett Cancer Center (@buffettcancer) 's Twitter Profile Photo

Proud to be 1 of only 73 NCI-designated Cancer Centers in the US and the ONLY one in #Nebraska! This designation recognizes our commitment to pioneering research and exceptional patient care. #NCRM25

Proud to be 1 of only 73 NCI-designated Cancer Centers in the US and the ONLY one in #Nebraska! This designation recognizes our commitment to pioneering research and exceptional patient care. #NCRM25
Women in Lymphoma - wil@lymphoma.org.au (@womeninlymphoma) 's Twitter Profile Photo

Going to ASCO this weekend? Come say hi to our team Ann LaCasce, MD , Nina Shah , David Wright & see our global Gender Equity Survey results poster board 396, June 1st, 9-12pm More details about the survey to come at our EHA presentation June 14th, 5:15pm in Amber Hall 3+4

Women Leaders in Oncology (@wearewlo) 's Twitter Profile Photo

Thank you to our incredible sponsors for making the Women Leaders in Oncology and Allies Event possible! We’re proud to celebrate impactful leaders, strengthen meaningful connections, and work together to advance cancer care. #WomenInOncology #WLO2025

Thank you to our incredible sponsors for making the Women Leaders in Oncology and Allies Event possible!

We’re proud to celebrate impactful leaders, strengthen meaningful connections, and work together to advance cancer care.

#WomenInOncology #WLO2025
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

#ASCO25 | Julie Vose just outlined how and when to use epcoritamab in patients with relapsed or refractory follicular lymphoma. ASCO #LYMsm #NonHodgkinLymphoma #ImmunoOnc

#ASCO25 | <a href="/DrJulieVose/">Julie Vose</a> just outlined how and when to use epcoritamab in patients with relapsed or refractory follicular lymphoma.

<a href="/ASCO/">ASCO</a> #LYMsm #NonHodgkinLymphoma #ImmunoOnc
Julie Vose (@drjulievose) 's Twitter Profile Photo

Interesting #ASCO25 session on incorporating new agents into standard practice. Fun to compare new agents used to treat lung, breast cancer, CNS, and lymphoma: how to use them in the community.

Daniel Auclair (@auclairdan) 's Twitter Profile Photo

Sunday #ASCO25 #lymsm posters Abstract 7043: New 3-year F/U of pivotal EPCORE NHL-1 study; in subgroup analysis of subjects who remained in CR 2 years post epco, 96% are alive and in CR at 3 years with median DOCR, PFS and OS not reached Julie Vose

Sunday #ASCO25 #lymsm posters

Abstract 7043: New 3-year F/U of pivotal EPCORE NHL-1 study; in subgroup analysis of subjects who remained in CR 2 years post epco, 96% are alive and in CR at 3 years with median DOCR, PFS and OS not reached <a href="/DrJulieVose/">Julie Vose</a>
UNMC CON (@unmccon) 's Twitter Profile Photo

Helping out with the Cattlemen's Ball is a top highlight of @UNMC College of Nursing students and personnel each year! The festivities for the 2025 event kick off on June 6. See how this one-of-a-kind event provides valuable support for cancer research ow.ly/63QI50W41Mp

UNMC Innovation Fund (@unmcfund) 's Twitter Profile Photo

This month is National Cancer Survivors Month and today we want to recognize our friends and partners at Fred & Pamela Buffett Cancer Center and all the work they do to make sure Nebraskans don't face the battle of cancer alone.

This month is National Cancer Survivors Month and today we want to recognize our friends and partners at <a href="/BuffettCancer/">Fred & Pamela Buffett Cancer Center</a> and all the work they do to make sure Nebraskans don't face the battle of cancer alone.
CancerNetwork® (@cancernetwrk) 's Twitter Profile Photo

Results from the EPCORE NHL-1 trial shared at the 2025 ASCO Annual Meeting found positive responses in patients with relapsed/refractory large B-cell lymphoma. #lymsm #ASCO25 | Julie Vose hubs.li/Q03qZCft0